ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2011

Novel Somatic Mutations Identified by Whole Genome Sequencing of Rheumatoid Arthritis (RA) Fibroblast-Like Synoviocytes (FLS)

Richard Ainsworth 1, Deepa Hammaker 2, David Boyle 1, Rizi Ai2, Jeremy Sokolove 3, Wei Wang 1 and Gary Firestein 2, 1University of California, San Diego, San Diego, CA, 2University of California, San Diego, San Diego, 3AbbVie Immunology Clinical Development, Redwood City

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fibroblast-ilke synoviocytes and somatic mutations, Rheumatoid arthritis (RA), whole genome sequencing

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Somatic mutations caused by reactive oxygen and nitrogen species in inflamed joints, have been implicated in the destructive nature of RA. Mutation analysis also helps identify mechanisms contributing to the aggressive behavior of RA FLS. However, previous analyses focused on candidate gene approaches. This work represents the first whole genome sequencing study of RA FLS.

Methods: Next generation sequencing of the whole genome was carried out for 10 RA and 10 osteoarthritis (OA) human FLS cell lines at 100X. Reads were aligned, sorted according to chromosome and position, duplicates and those with a MAQ score < 30 removed. Base quality score recalibration of aligned reads was then performed with GATK 3.8. Variant calling was performed using VarScan2 with low quality base calls of < Q20 filtered out. Finally, we removed low coverage and low confidence sites. To account for a lack of a germline reference for each line and potential culture effects, we used a novel approach by filtering for sequences with mutation frequencies (MF) in >2% and < 5-8% of reads and discarding those found in at least >92% of the reads to remove putative germline polymorphsms and identify somatic mutations. For each set of mutations, single nucleotide variants (SNV) and insertion/deletion (Indel) locations were overlapped with gene bodies and promoters to identify the associated genes or with gene exons only. Genes specific to RA were analyzed for enriched functions and pathways.

Results: Indel and Missense SNV somatic mutations in the range 2%< MF< 5% were overlapped with gene bodies and promoters. Mutated genes unique to RA were identified and ranked by the number of RA cell lines with the mutant gene. Only 43 genes had mutations in > 5/10 RA lines and 0/10 OA lines. The top ranking genes, which had 7/10 RA lines with intronic mutations included MTMR3, which plays a role in autophagosome formation and CLNK which plays a role in immunoreceptor signaling. Other RA-specific mutated genes included multiple E3 ubiquitin ligases and DNA repair genes. Using the same filter and overlapping somatic mutations only with exons yielded additional RA-specific genes. Of the 33 exon-only mutations in 3/10 or more RA lines and 0/10 OA lines, 5 are also unexpectedly involved ubiquitination. We then extended the mutation range to 2%< MF< 6% and only considered missense somatic mutations in exons. 260 and 207 genes unique to RA or OA, respectively, were identified. Pathway analysis on these gene sets identified 11 significant pathways (p< 1 x10-5 ) for the RA genes but no significant pathways for OA suggesting that the latter were not functionally relevant. 3 of the mutant RA pathways involved antigen processing including “Antigen Presentation: Folding, assembly and peptide loading of class 1 MHC” (p< 1 x10-16).

Conclusion: Whole genome sequencing of RA and OA human FLS lines identified somatic mutations unique to RA in genes consistent with immune deregulation. Our novel computational approach corrected for potential tissue culture effects and showed a high mutation rate in RA. The unbiased analysis showed significant mutant pathways enriched in RA and suggests that the mutations play a role in disease pathogenesis.


Disclosure: R. Ainsworth, None; D. Hammaker, None; D. Boyle, Janssen, 2; R. Ai, None; J. Sokolove, AbbVie, 3, 4; W. Wang, None; G. Firestein, Abbvie, 2, Janssen, 2.

To cite this abstract in AMA style:

Ainsworth R, Hammaker D, Boyle D, Ai R, Sokolove J, Wang W, Firestein G. Novel Somatic Mutations Identified by Whole Genome Sequencing of Rheumatoid Arthritis (RA) Fibroblast-Like Synoviocytes (FLS) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/novel-somatic-mutations-identified-by-whole-genome-sequencing-of-rheumatoid-arthritis-ra-fibroblast-like-synoviocytes-fls/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-somatic-mutations-identified-by-whole-genome-sequencing-of-rheumatoid-arthritis-ra-fibroblast-like-synoviocytes-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology